相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy
Mireille Alhouayek et al.
DRUG DISCOVERY TODAY (2014)
More surprises lying ahead. The endocannabinoids keep us guessing
Daniele Piomelli
NEUROPHARMACOLOGY (2014)
The anticancer antibiotic mithramycin-A inhibits TRPV1 expression in dorsal root ganglion neurons
K. Zavala et al.
NEUROSCIENCE LETTERS (2014)
Structure activity relationship of synaptic and junctional neurotransmission
Raj K. Goyal et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2013)
A GPR18-based signalling system regulates IOP in murine eye
Meggie D. Caldwell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Metabolism of endocannabinoids and related N-acylethanolamines: Canonical and alternative pathways
Natsuo Ueda et al.
FEBS JOURNAL (2013)
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
Slava Rom et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis
Yu Y. Li et al.
LABORATORY INVESTIGATION (2013)
Inhibitory Effect of N-Acyl Dopamines on IgE-Mediated Allergic Response in RBL-2H3 Cells
Jae-Myung Yoo et al.
LIPIDS (2013)
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice
Huan Gui et al.
MEDIATORS OF INFLAMMATION (2013)
N-Arachidonyl Glycine Does Not Activate G Protein-Coupled Receptor 18 Signaling via Canonical Pathways
Van B. Lu et al.
MOLECULAR PHARMACOLOGY (2013)
The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes
Alexandra Wojtalla et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells
Douglas McHugh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Activation of endothelial TLR2 by bacterial lipoprotein upregulates proteins specific for the neutrophil response
Kevin Wilhelmsen et al.
INNATE IMMUNITY (2012)
ERK5 Protein Promotes, whereas MEK1 Protein Differentially Regulates, the Toll-like Receptor 2 Protein-dependent Activation of Human Endothelial Cells and Monocytes
Kevin Wilhelmsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Endothelial Cell Peroxisome Proliferator-Activated Receptor γ Reduces Endotoxemic Pulmonary Inflammation and Injury
Aravind T. Reddy et al.
JOURNAL OF IMMUNOLOGY (2012)
TRPV1 Deletion Enhances Local Inflammation and Accelerates the Onset of Systemic Inflammatory Response Syndrome
Elizabeth S. Fernandes et al.
JOURNAL OF IMMUNOLOGY (2012)
Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions
Servio H. Ramirez et al.
JOURNAL OF NEUROSCIENCE (2012)
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids
Antonio Luchicchi et al.
MOLECULAR NEUROBIOLOGY (2012)
Endocannabinoid Signaling and Synaptic Function
Pablo E. Castillo et al.
NEURON (2012)
The evolution and comparative neurobiology of endocannabinoid signalling
Maurice R. Elphick
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
The Cannabinoid 2 Receptor as a Potential Therapeutic Target for Sepsis
Kevin Richard Kasten et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
Prostaglandins and Inflammation
Emanuela Ricciotti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Endothelial activation, dysfunction and permeability during severe infections
Warren L. Lee et al.
CURRENT OPINION IN HEMATOLOGY (2011)
Calcium channel blockers and modulation of innate immunity
Wenling Liu et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
What is the natural ligand of GPR55?
Toshiaki Okuno et al.
JOURNAL OF BIOCHEMISTRY (2011)
Bacterial Lipoprotein TLR2 Agonists Broadly Modulate Endothelial Function and Coagulation Pathways In Vitro and In Vivo
Hae-Sook Shin et al.
JOURNAL OF IMMUNOLOGY (2011)
Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit
Mauricio Rosas-Ballina et al.
SCIENCE (2011)
Rimonabant inhibits TNF-α-induced endothelial IL-6 secretion via CB1 receptor and cAMP-dependent protein kinase pathway
Nan-lan Huang et al.
ACTA PHARMACOLOGICA SINICA (2010)
Endogenous N-acyl-dopamines induce COX-2 expression in brain endothelial cells by stabilizing mRNA through a p38 dependent pathway
Carmen M. Navarrete et al.
BIOCHEMICAL PHARMACOLOGY (2010)
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
Douglas McHugh et al.
BMC NEUROSCIENCE (2010)
Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells
Mohanraj Rajesh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Inhibition of monoacylglycerol lipase by troglitazone, N-arachidonoyl dopamine and the irreversible inhibitor JZL184: comparison of two different assays
E. Bjorklund et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists
R. G. Pertwee
CURRENT MEDICINAL CHEMISTRY (2010)
Proinflammatory Activation Pattern of Human Umbilical Vein Endothelial Cells Induced by IL-1β, TNF-α, and LPS
Veronika Mako et al.
CYTOMETRY PART A (2010)
DETAILED CHARACTERISATION OF CB2 RECEPTOR PROTEIN EXPRESSION IN PERIPHERAL BLOOD IMMUNE CELLS FROM HEALTHY HUMAN VOLUNTEERS USING FLOW CYTOMETRY
E. S. Graham et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2010)
Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells
Ewa Kozela et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages
Ming-xiu Hao et al.
JOURNAL OF LIPID RESEARCH (2010)
Signal transduction of the CB1 cannabinoid receptor
Gabor Turu et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2010)
Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels
Luciano De Petrocellis et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation
Khadija Alawi et al.
PHARMACOLOGY & THERAPEUTICS (2010)
An introduction to the endocannabinoid system: from the early to the latest concepts
Luciano De Petrocellis et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand
Takayuki Sugiura
BIOFACTORS (2009)
Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine
Hamish R. Ross et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Role of endocannabinoids and endovanilloids in Ca2+ signalling
Luciano De Petrocellis et al.
CELL CALCIUM (2009)
TRPA1-mediated responses in trigeminal sensory neurons: interaction between TRPA1 and TRPV1
Margaux M. Salas et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Molecular mechanisms of endothelial hyperpermeability: implications in inflammation
Puneet Kumar et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Cannabinoids as novel anti-inflammatory drugs
Prakash Nagarkatti et al.
FUTURE MEDICINAL CHEMISTRY (2009)
The Cannabinoid Receptor 2 Is Critical for the Host Response to Sepsis
Johannes Tschoep et al.
JOURNAL OF IMMUNOLOGY (2009)
Discovery of 1-[9-(4-Chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic Acid Amide Hydrochloride (CP-945,598), a Novel, Potent, and Selective Cannabinoid Type 1 Receptor Antagonist
David A. Griffith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Opposite effects of anandamide and n-arachidonoyl dopamine in the regulation of prostaglandin E2 and 8-iso-PGF2α formation in primary glial cells
Carmen M. Navarrete et al.
JOURNAL OF NEUROCHEMISTRY (2009)
A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules
L. Mestre et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine
Sherry Shu-Jung Hu et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2009)
Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPAR gamma)
Saoirse E. O'Sullivan et al.
PPAR RESEARCH (2009)
Standardization of real-time PCR gene expression data from independent biological replicates
Erik Willems et al.
ANALYTICAL BIOCHEMISTRY (2008)
Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression
Markus Waldeck-Weiermair et al.
JOURNAL OF CELL SCIENCE (2008)
Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells
Tzong-Shi Lu et al.
JOURNAL OF IMMUNOLOGY (2008)
Antioxidant and neuroprotective properties of N-arachidonoyldopamine
Mikhail Yu. Bobrov et al.
NEUROSCIENCE LETTERS (2008)
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
D. G. Johns et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin
Natalie Clark et al.
FASEB JOURNAL (2007)
Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells
Christiane A. Opitz et al.
FEBS LETTERS (2007)
CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion
Mohanraj Rajesh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Oxidative metabolism of lipoamino acids and vanilloids by lipoxygenases and cyclooxygenases
Jeffery J. Prusakiewicz et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
PPARα in atherosclerosis and inflammation
Fokko Zandbergen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase
Sandor Batkai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
The rat vanilloid receptor splice variant VR.5′sv blocks TRPVI activation
Helge Eilers et al.
NEUROREPORT (2007)
Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): Effect of cAMP, cannabinoid CB, receptors and endovanilloids
Luciano De Petrocellis et al.
EXPERIMENTAL CELL RESEARCH (2007)
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
Arpad Szallasi et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors
Silvia Marinelli et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Cannabinoid pharmacology: the first 66 years
RG Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Ca2+ signaling, TRP channels, and endothelial permeability
Chinnaswamy Tiruppathi et al.
MICROCIRCULATION (2006)
Cannabinoids and PPARα signalling
Y. Sun et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons;: the role of CB1 receptors
P. J. Millns et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons
Nathaniel A. Jeske et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18
Masashi Kohno et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators
Heather B. Bradshaw et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin
Amol M. Patwardhan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cannabinoid signalling in TNF-α induced IL-8 release
Maria E. Mormina et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Store-operated calcium channels and pro-inflammatory signals
Wei-chiao Chang
ACTA PHARMACOLOGICA SINICA (2006)
Perivascular nerves and the regulation of cerebrovascular tone
E Hamel
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Enhancement of spontaneous and heat-evoked activity in spinal nociceptive neurons by the endovanilloid/endocannabinoid N-arachidonoyldopamine (NADA)
SM Huang et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease
H Girouard et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes
M Gokoh et al.
FEBS LETTERS (2005)
Effects of cannabinoid treatment on Chagas disease pathogenesis: balancing inhibition of parasite invasion and immunosuppression
JL Croxford et al.
CELLULAR MICROBIOLOGY (2005)
Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine
R Sancho et al.
JOURNAL OF IMMUNOLOGY (2005)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons
TJ Price et al.
NEUROPHARMACOLOGY (2005)
AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties
NR Gavva et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes
WS Sheng et al.
GLIA (2005)
Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
JL Croxford et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide
TJ Price et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Enhancement of potency and efficacy of NADA by PKC-mediated phosphorylation of vanilloid receptor
LS Premkumar et al.
JOURNAL OF NEUROPHYSIOLOGY (2004)
Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)
SE O'Sullivan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Immunosuppressive activity of endovanilloids:: N-arachidonoyl-dopamine inhibits activation of the NF-κB, NFAT, and activator protein 1 signaling pathways
R Sancho et al.
JOURNAL OF IMMUNOLOGY (2004)
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
B Costa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors
SA Golech et al.
MOLECULAR BRAIN RESEARCH (2004)
New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation
T Sugiura et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
TRPV1 and CB1 receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat
DR Sagar et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components
J Talreja et al.
IMMUNOLOGY (2004)
The cannabinoid system and immune modulation
TW Klein et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Capsaicin-like effects of N-arachidonoyl-dopamine in the isolated guinea pig bronchi and urinary bladder
S Harrison et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
WC Aird
BLOOD (2003)
N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia
CJ Chu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
H Wang et al.
NATURE (2003)
Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide
F Facchinetti et al.
GLIA (2003)
Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes
MD Southall et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation
G Bhave et al.
NEURON (2002)
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
SM Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Molecular basis for species-specific sensitivity to hot chili peppers
SE Jordt et al.
CELL (2002)
Receptor-operated Ca2+ influx channels in leukocytes:: a therapeutic target?
SW Li et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1
Z Olah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide
V Vellani et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Differential expression of cannabinoid CB2 receptor mRNA in mouse immune cell subpopulations and following B cell stimulation
SF Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism
L De Petrocellis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine
V Bezuglov et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: Involvement of eicosanoids
YH Chang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
N-acyl-dopamines:: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo
T Bisogno et al.
BIOCHEMICAL JOURNAL (2000)
Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity
L De Petrocellis et al.
FEBS LETTERS (2000)
2-arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-α production in murine macrophages, and in mice
R Gallily et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Functional CB1 cannabinoid receptors in human vascular endothelial cells
J Liu et al.
BIOCHEMICAL JOURNAL (2000)
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol
CJ Hillard
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2000)
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor -: Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells
T Sugiura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
